MEANS FOR REGULATION OF THE MENSTRUAL CYCLE IN SECONDARY NORMOGONADONTROPIC AMENORA AND OLIGOMENORA AND METHOD OF TREATMENT

摘要

1. the use of dried u0434u0435u0444u0438u0431u0440u0438u043du0438u0440u043eu0432u0430u043du043du043eu0439 or u043du0435u0434u0435u0444u0438u0431u0440u0438u043du0438u0440u043eu0432u0430u043du043du043eu0439 blood taint, u0438u0437u044eu0431u0440u0430 or u043fu00a0u0442u043du0438u0441u0442u043eu0433u043e u043eu043bu0435u043du00a0 as a means of regulating the menstrual cec l in the treatment of secondary amenorrhea and u043du043eu0440u043cu043eu0433u043eu043du0430u0434u043eu0442u0440u043eu043fu043du043eu0439 u043eu043bu0438u0433u043eu043cu0435u043du043eu0440u0435u0438.;2. method u043du043eu0440u043cu043eu0433u043eu043du0430u0434u043eu0442u0440u043eu043fu043du043eu0439 u043bu0435u0447u0435u043du0438u00a0 secondary amenorrhea and u043eu043bu0438u0433u043eu043cu0435u043du043eu0440u0435u0438, u0437u0430u043au043bu044eu0447u0430u044eu0449u0438u0439u0441u00a0 of oral pharmacological treatment, u043eu0442u043bu0438u0447u0430u044eu0449u0438u0439u0441u00a0, appoint u0432u044bu0441u0443 u0448u0435u043du043du0443u044e u0434u0435u0444u0438u0431u0440u0438u043du0438u0440u043eu0432u0430u043du043du0443u044e or u043du0435u0434u0435u0444u0438u0431u0440u0438u043du0438u0440u043eu0432u0430u043du043du0443u044e blood taint, u0438u0437u044eu0431u0440u0430 or u043fu00a0u0442u043du0438u0441u0442u043eu0433u043e u043eu043bu0435u043du00a0.;3. method for u043eu0442u043bu0438u0447u0430u044eu0449u0438u0439u0441u00a0 2, so that the oral u0432u044bu0441u0443u0448u0435u043du043du0443u044e u0434u0435u0444u0438u0431u0440u0438u043du0438u0440u043eu0432u0430u043du043du0443u044e or u043du0435u0434u0435u0444u0438u0431u0440u0438u043du0438u0440u043eu0432u0430u043du043du0443u044e blood taint, u0438u0437u044eu0431u0440u0430 or u043fu00a0u0442u043du0438u0441u0442u043eu0433u043e u043eu043bu0435u043du00a0 designate 25 mg (1 capsule) once a day, a course of 15 - 25 days, 3 year intervals in 3 to 7 days.